- Are we playing technology catch-up: What can we learn and adapt from other industries, and how can we implement this on scale despite increased regulation?
- Lots of clinical management systems are generic but do we have ones that are clinically focused: Are you reaching the right audience in the right way and how can CROs get recognized by biotechs?
- Recognizing the impact of technology solutions on the patients journey and ways to progress this even further
- How do smaller biotechs prepare their supply chains for IRT adoption and compliance?
Chair: Joshua Cox, Vice President of Clinical Data & Analytics Capabilities, Eli Lilly and Company